Read our latest advice on Coronavirus (COVID-19)

Our services are open and safe to attend – we are still here to help

Gaya, Andrew - consultant clinical oncologist


Consultant profiles

Andrew Gaya


Tel: 020 7188 4249
Fax:020 7188 4271
Secretary's email:

Area of expertise: cancer
Tumour specialty group:upper GI, colorectal, skin

  • Biography

    Andrew Gaya qualified in London, where he was awarded a distinction and several academic prizes. He trained in clinical oncology at Imperial College and St Bartholomew's Hospital and subsequently undertook a Cancer Research MD fellowship at University College London.

    Dr Gaya treats solid tumours using chemotherapy, radiotherapy and biological therapies. His main focus is on colorectal cancer, cancers of the oesophagus, stomach, pancreas and liver.

    Dr Gaya's main research interests are functional cancer imaging, where he is looking for ways to assess response to treatment much earlier, and techniques for assessing blood flow and oxygen levels within cancers. He is also interested in developing drug treatments that can cut off the blood supply to cancers, or stop cancers making new blood vessels.

    He is heavily involved with the implementation of the latest radiotherapy techniques such as IMRT, IGRT and tomotherapy, and stereotactic body radiosurgery. 

    He has published widely in peer reviewed journals. He is a principle investigator on a number of national and international clinical trials.

  • Education and training

    • 1992: BSc University of london, 1st class honours
    • 1995: MB BS University of London
    • 1999: MRCP UK 
    • 2002: FRCR UK
    • 2009: MD (UCL)
  • Specialist interests

    • Oesophageal cancer
    • Gastric (stomach) cancer
    • Pancreas cancer
    • Liver cancer
    • Colon cancer
    • Rectal cancer
    • Anal cancer
    • Chemotherapy, radiotherapy, stereotactic radiotherapy
    • Functional imaging
    • Immunotherapy
  • Research interests

    • Functional imaging
    • Immunotherapy
    • Stereotactic radiotherapy 
    • Vascular targeting